Daewoong gets US prequalification approval for carbapenem antibiotic
Published: 2013-09-04 06:56:00
Updated: 2013-09-04 06:56:00
A Korean antibiotic drug has won prequalification approval from the Food and Drug Administration of the United States for sale in the country, the company said Monday, a move that will give the local drugmaker access to the world’s largest market.
The drug developed by Daewoong Pharmaceutical ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
